Anti- Ageing and Reproductive Medical Giants to Gather in Hong Kong, Dragon’s Medical Leads Chinese Medical Development
Hong Kong, June 2, 2023 /PRNewswire/ -- Dragon's Medical will hold its Advance Medical Technology Press Conference 2023 at W Hong Kong on Jun 9, 2023, signing strategic partnership agreements with various medical groups from China, Hong Kong and Taiwan, deepening their long-term strategic partnership. At the event, Dragon's Medical announces the launch of their new brand, introduces their...
United Imaging to Unveil Ultra-Modern MRI Technology Platform at ISMRM in Toronto
In addition to the uMR® Jupiter 5T, the 12-year old company will exhibit its uAIFi artificial intelligence technology platform and translational medical research systems, and present an open MR development platform that includes AI-empowered reconstruction. HOUSTON, June 2, 2023 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, is a Silver sponsor...
Trajan’s Microsampling Devices Meet IVDR Compliance in Europe, UK
Mitra® and hemaPEN® receive regulatory certification as medical devices for remote blood sample collection in healthcare, clinical trials and home monitoring programs in Europe and United Kingdom. MELBOURNE, Australia, June 2, 2023 /PRNewswire/ -- Trajan Scientific and Medical, a leading provider of analytical and life sciences products and solutions, today announced the...
Transcenta Holding Limited (6628.HK) to Hold 2023 ASCO Business Update call Conference.
SUZHOU, China, June 2, 2023 /PRNewswire/ -- The management team of Transcenta Holding Limited (06628.HK) will attend the 2023 ASCO Business Update Call conference on June 7, 2023. Transcenta is a clinical stage biopharmaceutical company with fully integrated capabilities in the discovery, research, development, and manufacture of antibodies-based therapeutics. Meeting Details: Meeting Date: Wednesday, June...
Latest Updates of 9 Viva’s Portfolio Companies
HONG KONG, June 2, 2023 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and the success of commercialization. Recently, 9 of Viva's portfolio companies have achieved significant results and progress. Keep reading for...
Waterdrop Inc. Announces First Quarter 2023 Unaudited Financial Results
BEIJING, June 2, 2023 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced its unaudited financial results for the first quarter ended March 31, 2023. Financial and Operational Highlights for the First Quarter of 2023 Resilient Business Performance:...
Invivoscribe Partners with Complete Genomics to Develop and Commercialize Biomarker Tests for Oncology and Cancer Research
SAN DIEGO and SAN JOSE, Calif., June 2, 2023 /PRNewswire/ -- Invivoscribe and Complete Genomics announced today that they had entered a partnership to develop and commercialize biomarker tests on Complete Genomics' NGS platforms. The territory is worldwide, and the field is oncology and cancer research. Under the terms of the...
TWi Biotechnology Exploring Promising Treatment for Granuloma Annulare (GA)
Company and Yale University Hospital seeking participants with GA for Phase 1 trials of medicine FDA-approved for other ailments NEW HAVEN, Conn., June 2, 2023 /PRNewswire/ -- TWi Biotechnology (TWiB), a clinical stage biopharmaceutical company specializing in development of repositioned drugs for unmet medical needs, is currently seeking participants for a Phase 1 clinical trial of a topical gel...
Sunway Medical Centre Velocity Awarded by Frost & Sullivan for Leading the Malaysian Hospital Industry with Holistic Medical Care and Pioneering Technologies
Sunway Medical Centre Velocity in Kuala Lumpur delivers a wide range of medical specialties supported by highly trained professionals and advanced technologies. SAN ANTONIO, June 2, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the Malaysian hospital industry and, based on its findings, recognizes Sunway Medical Centre Velocity (SMCV) with the 2023 Emerging Hospital Company of the Year Award. Since...
NMPA accepted Akeso’s ebronucimab (PCSK9) marketing application in two cardiovascular indications
HONG KONG, June 2, 2023 /PRNewswire/ -- Akeso Inc. (9926. HK, "Akeso") announced today that China's National Medical Products Administration (NMPA) has accepted its New Drug Application (NDA) for its fully human anti-PCSK9 monoclonal antibody ebronucimab (AK102) for 2 indications 1) primary hypercholesterolemia and mixed hyperlipidemia, and 2) heterozygous familial hypercholesterolemia (HeFH). Ebronucimab is jointly developed by Akeso and...
